Here is something most injection guides will not tell you: the question is not really "which neuromodulator is best?" The question is "which one is best for your face, your lifestyle, and your treatment goals?" Botox, Dysport, and Xeomin are all FDA-approved botulinum toxin type A products. They all work by temporarily interrupting the nerve signals that cause facial muscles to contract. But beyond that shared mechanism, the differences between them matter more than the average patient realizes, and choosing the wrong one for your face type or treatment area can mean slower onset, shorter duration, or results that simply do not look right on your specific anatomy.
At our Manhattan locations, we have been administering all three of these neuromodulators since their respective FDA approvals, and the nuances we have observed across thousands of treatments inform everything in this guide. This is not a paid ranking or a brand endorsement. It is an honest, provider-backed breakdown of how these products actually perform in real treatment rooms across our Flatiron, Union Square, Midtown East, Upper West Side, and Tribeca locations, as well as our Boston and Miami Beach practices.
Whether you are searching for Botox near me for the first time or you are a seasoned injectable client wondering if Dysport or Xeomin might serve you better, this article gives you the clinical detail you need to walk into your consultation already informed.
Why Three Products Exist for the Same Job
All three neuromodulators share the same active ingredient, botulinum toxin type A, but they are not identical formulations. Understanding why these products differ structurally helps explain why they behave differently in tissue, why dosing is not interchangeable, and why an experienced injector chooses one over another based on the treatment area and patient profile.
Botox (onabotulinumtoxinA), manufactured by Allergan Aesthetics (now AbbVie), is the product that essentially created the modern neuromodulator category. It has the longest clinical track record and the broadest FDA-approved indication list of any botulinum product available today. Its formulation includes the toxin protein complex alongside accessory proteins.
Dysport (abobotulinumtoxinA), developed by Ipsen and marketed in the US by Galderma, has been widely used in Europe since the early 1990s and received FDA approval in the US in 2009. Its formulation uses a different protein complex configuration and a smaller toxin molecule, which contributes to its characteristic diffusion behavior, it tends to spread more broadly in tissue than Botox at equivalent clinical doses.
Xeomin (incobotulinumtoxinA), produced by Merz Aesthetics, is structurally distinct from both. It is formulated without the accessory proteins ("naked toxin"), which means it carries no complexing proteins at all. This is not just a manufacturing detail, it has genuine clinical implications for patients who have developed antibody resistance to other neuromodulators, and it eliminates any concern about protein load sensitization over time.
The practical consequence of these structural differences is that dosing units are not interchangeable across products. Dysport units are typically dosed at roughly two to three times the number of Botox units to achieve an equivalent effect, while Xeomin and Botox have a closer to one-to-one unit ratio in most treatment areas. An injector who quotes you "20 units of Dysport" is not giving you less product than "20 units of Botox", they are using a different measurement scale entirely. This is one of the most common sources of confusion we see in consultations with clients who have received quotes from multiple providers.
Botox: The Benchmark That Every Other Neuromodulator Is Measured Against
Botox remains the most widely recognized and most frequently administered neuromodulator in the world. For most patients, especially those new to anti-aging injections, it serves as a reliable, well-characterized starting point with a safety profile backed by decades of clinical use.
How Botox Performs in Clinical Settings
Onset is typically 3–7 days for initial effects, with full results visible at around 10–14 days. Duration for most patients in most areas is 3–4 months, though this varies meaningfully based on the treatment zone, the patient's muscle mass, their metabolism, and how consistently they have maintained a treatment schedule over time. Patients who have been on a consistent schedule for several years often find their results last longer because the underlying muscle activity has been progressively reduced.
Botox has a moderate diffusion radius, which makes it well-suited to precise, targeted applications where you want the product to stay close to the injection site. This is particularly relevant for areas like the orbicularis oculi (around the eye), the lip border, and the neck bands (platysma), where you want intentional, controlled placement without inadvertent spread into adjacent muscle groups.
Ideal Treatment Areas for Botox
- Forehead lines: Botox for forehead is one of the most common requests we receive across all of our locations. Its predictable spread makes it easier to calibrate the balance between softening lines and preserving natural expressivity.
- Glabellar lines (11s): The frown lines between the brows are among the most studied Botox applications, and it performs consistently here.
- Crow's feet: Precise lateral orbital placement is well-suited to Botox's diffusion characteristics.
- Brow lifting: Strategic placement for a subtle arch requires precision over spread.
- Lip lines and perioral area: Small, precise doses benefit from controlled diffusion.
- Jaw slimming (masseter): One of the more nuanced applications, where Botox's predictability helps avoid unintended spread to adjacent chewing muscles.
- Hyperhidrosis (excessive sweating): FDA-approved for axillary hyperhidrosis, and widely used off-label for palms and soles.
Botox: Honest Pros and Cons
| Factor | Assessment |
|---|---|
| Onset speed | ⚠️ Moderate, 3–7 days initial, full effect at 10–14 days |
| Duration | ✅ 3–4 months average, up to 6 months in some consistent patients |
| Precision | ✅ High, controlled diffusion radius |
| Track record | ✅ Longest of any neuromodulator; most studied |
| Storage requirements | ⚠️ Requires refrigeration; shorter shelf life once reconstituted |
| Antibody resistance risk | ⚠️ Low but possible with high-frequency, high-dose use over many years |
| Price per treatment | ⚠️ Typically priced per unit; total cost varies by area and units needed |
| Ideal for first-timers | ✅ Yes, familiar to most providers, easiest to adjust |
Botox is the product most providers feel most comfortable with, which itself is a meaningful clinical advantage. When you are searching for Botox near me, you are looking not just for the product but for the provider experience behind it, and Botox's ubiquity means the talent pool of skilled injectors is the deepest for this product specifically.
Dysport vs Botox: Where the Differences Actually Show Up
The Dysport vs Botox debate is the most common comparison question we field at our treatment rooms, and the honest answer is that both products are excellent, but they genuinely are not interchangeable for every use case. Dysport has specific characteristics that make it a superior choice in some scenarios and a less ideal one in others.
The Diffusion Difference: Why It Matters More Than You Think
Dysport's defining clinical characteristic is its tendency to diffuse more broadly through tissue than Botox at comparable clinical doses. This is not a flaw, in the right hands, for the right treatment area, it is a genuine advantage. But it requires an injector who fully understands how to work with this property rather than against it.
In large, flat muscle groups like the frontalis (the forehead muscle responsible for horizontal lines), broader diffusion means you may need fewer injection points to achieve even coverage. This translates to a more uniform result across the forehead with less risk of banding, those uneven horizontal stripes that can occur when Botox is placed too conservatively in this area.
For crow's feet, the broader diffusion can also be beneficial, reaching the full extent of the lateral orbital muscle with fewer injections. However, this same property requires careful technique near the eyes to avoid inadvertent spread into the levator palpebrae muscle (which lifts the eyelid), a complication that causes temporary eyelid drooping and that is far more likely with imprecise technique than with the product itself.
Onset: Dysport's Clearest Advantage
Dysport consistently demonstrates faster onset than Botox. Most patients see initial effects within 24–48 hours, with full results visible around 10–12 days. For Botox, initial effects typically begin at 3–7 days. This distinction matters for clients with event-driven timelines. If you have a wedding, a major presentation, or a significant event in the next week, Dysport gives you more predictable timing on when you will see results.
In our Boston Back Bay location, we see a lot of clients preparing for professional events and speaking engagements, and faster onset is a frequent deciding factor in their product selection.
Duration: Roughly Equivalent, with Some Patient-Specific Variation
Dysport's duration is broadly comparable to Botox, typically 3–4 months, with some patients reporting slightly longer duration in certain areas. The clinical literature does not strongly favor one over the other on duration, and in our practice we find it is more variable by patient than by product. Metabolism, muscle mass, activity level, and treatment history all influence how long either product lasts.
Ideal Candidates for Dysport
- Patients with larger or stronger frontalis muscles who need broader coverage of the forehead
- Clients who have found Botox results inconsistent across the forehead (banding or uneven softening)
- Patients with time-sensitive treatment windows who need faster onset
- Individuals who have been long-term Botox users and feel their results are diminishing (sometimes switching products refreshes the response)
- Patients with crow's feet who want broad, even softening of the entire lateral orbital region
Where Dysport Is Not the Best Choice
The broader diffusion profile makes Dysport a less ideal choice for highly precise applications where you specifically want the product to stay in a small, defined area. Lip lines, brow shaping with very targeted placement, and lower face work near the depressor muscles are all areas where Botox or Xeomin's more contained diffusion gives the injector greater control. This is not about product quality, it is about matching tool to task.
Xeomin: The Case for the "Naked" Neuromodulator
Xeomin occupies a genuinely distinct clinical niche that is often underexplained in consumer-facing content. It is not simply a "generic" version of Botox, as some patients mistakenly assume. Its stripped-down formulation has real clinical implications that make it the best choice for a specific subset of patients.
What "Naked Toxin" Actually Means
When Allergan manufactures Botox and Ipsen manufactures Dysport, both formulations include the toxin protein bound to accessory proteins (sometimes called complexing proteins or hemagglutinins). These proteins are believed to be cleaved from the toxin once it reaches the neuromuscular junction, so they do not contribute to the product's mechanism of action, but they are present in the formulation and are delivered into the body alongside the active toxin.
Xeomin contains only the pure 150 kDa neurotoxin, with no accessory proteins. This has two practical consequences:
- Reduced antigenicity: The immune system's antibody response is more likely to be triggered by foreign proteins. With Xeomin, there are simply fewer proteins to react to. For patients who have been receiving neuromodulators for many years at high doses and frequency, this reduced protein load theoretically lowers the cumulative risk of developing neutralizing antibodies that diminish treatment efficacy over time.
- No refrigeration required: Xeomin is stable at room temperature until reconstituted, which has practical supply chain advantages for providers but is not clinically meaningful for patients.
Who Should Seriously Consider Xeomin?
The most compelling case for Xeomin is the patient who has been receiving neuromodulator treatments consistently for five or more years and has noticed that their results are not lasting as long as they used to, or that they need progressively higher doses to achieve the same effect. This pattern can indicate the development of neutralizing antibodies against the toxin complex proteins in their current product.
Switching to Xeomin removes the complexing protein component from the equation, which may restore responsiveness in these patients. This is one of the more nuanced conversations we have with long-term injectable clients at our Tribeca and Upper West Side locations, where we see many patients who have been receiving treatments since the early days of aesthetic neuromodulators.
Xeomin is also a reasonable choice for patients who:
- Have a known sensitivity history and want to minimize foreign protein exposure
- Are starting their injectable journey and want a product with the lowest theoretical immunogenicity profile
- Have achieved good results with Botox but want to explore whether Xeomin's slightly different diffusion behavior produces a different aesthetic outcome
Onset and Duration: How Xeomin Compares
Xeomin's onset is generally comparable to Botox, typically 3–7 days for initial effects, with full results at 10–14 days. Duration is similarly aligned with Botox at 3–4 months for most patients. Some clinical observations suggest that in certain patients, Xeomin may have a slightly slower onset than Botox, though this is not universally reported and may reflect individual variation more than a product-level difference.
The unit-to-unit dosing ratio between Xeomin and Botox is generally considered close to one-to-one in most treatment areas, which makes it easier to transition between the two products without significant recalibration of the treatment protocol.
Xeomin Honest Pros and Cons
| Factor | Assessment |
|---|---|
| Unique formulation | ✅ No accessory proteins, lowest protein load of all three |
| Antibody resistance | ✅ Theoretically lowest risk for long-term patients |
| Onset | ⚠️ Similar to Botox, 3–7 days; not as fast as Dysport |
| Duration | ✅ 3–4 months, comparable to Botox |
| Precision | ✅ Controlled diffusion, comparable to Botox |
| Storage | ✅ Room temperature stable (before reconstitution) |
| Provider familiarity | ⚠️ Less widely used than Botox, fewer providers have deep Xeomin experience |
| Best for | ✅ Long-term users, antibody concerns, patients wanting pure toxin |
Side-by-Side Comparison: Botox vs Dysport vs Xeomin
To make the clinical decision-making process more concrete, here is a comprehensive comparison matrix across the factors that matter most to patients and providers.
| Comparison Factor | Botox | Dysport | Xeomin |
|---|---|---|---|
| Manufacturer | Allergan/AbbVie | Ipsen/Galderma | Merz Aesthetics |
| FDA approval (US aesthetics) | 2002 | 2009 | 2011 |
| Formulation | Toxin + accessory proteins | Toxin + different protein complex | Pure toxin only (no accessory proteins) |
| Onset | 3–7 days | 24–48 hours | 3–7 days |
| Full results visible | 10–14 days | 10–12 days | 10–14 days |
| Average duration | 3–4 months | 3–4 months | 3–4 months |
| Diffusion/spread | Moderate, controlled | Broader (wider radius) | Moderate, controlled |
| Unit dosing equivalence | Reference standard (1:1 with Xeomin) | 2–3x Botox units for equivalent effect | ~1:1 with Botox |
| Best forehead application | ✅ Yes, standard choice | ✅ Excellent, broader coverage | ✅ Yes, comparable to Botox |
| Best for precise lower face work | ✅ High precision | ⚠️ Use with caution | ✅ High precision |
| Antibody resistance risk | Low | Low | Lowest |
| Ideal patient profile | First-timers, precise areas, most patients | Large muscle groups, event prep, forehead | Long-term users, protein-sensitive, antibody concerns |
Treatment Area Guide: Which Product Works Best Where?
Rather than thinking about neuromodulators in the abstract, the most useful framework is to think about them by treatment area. Each zone of the face has its own muscle anatomy, depth, and proximity to structures you want to protect, and these factors should drive product selection as much as patient preference.
Botox for Forehead: The Standard of Care
Botox for forehead treatment remains the most common injectable application across all of our locations. The frontalis muscle is broad and flat, running horizontally across the forehead, and its contraction creates the horizontal lines that most patients want to soften. The clinical goal is partial relaxation, enough to smooth the skin surface without completely immobilizing the brow, which creates a heavy, unnatural appearance.
All three neuromodulators work in the forehead, but Dysport's broader diffusion is particularly well-suited to patients with strong, thick frontalis muscles where achieving even coverage with Botox requires many injection points. In patients with thinner frontalis muscles or smaller foreheads, Botox or Xeomin's more contained diffusion gives the injector more control over the endpoint.
One of the most important technical considerations for forehead treatment is the relationship between the frontalis and the brow position. The frontalis is the primary brow elevator, and over-relaxing it (particularly in the medial forehead) can cause brow ptosis, a heaviness or drooping of the brow that gives patients a tired, unhappy appearance. This is a technique-related complication, not a product-related one, but it is more likely to occur with less experienced injectors regardless of which product they use.
Glabellar Lines (The "11s"): All Three Work Well
The glabellar complex (corrugator supercilii, procerus, and depressor supercilii muscles) is the most FDA-studied treatment zone for all three neuromodulators. The "11s" are the vertical lines between the brows that form during frowning and squinting. For most patients, 20–25 Botox units (or equivalent) adequately relaxes this area.
All three products perform well here. Provider preference and patient history tend to drive the selection more than any intrinsic advantage of one product over another in this specific zone. That said, patients who have had previous glabellar treatment with Botox and found results inconsistent or short-lived may benefit from trying Dysport (for faster onset and potentially broader coverage) or Xeomin (for lower protein load if antibody resistance is suspected).
Crow's Feet: Where Dysport Shines
The lateral orbital rhytids (crow's feet) result from the contraction of the orbicularis oculi muscle during smiling and squinting. The muscle wraps around the eye like a ring, and the lateral fibers are the primary target for crow's feet treatment.
Dysport's broader diffusion is a genuine advantage here, it can soften a wider area of the lateral orbital zone with fewer injections, producing a very even, natural-looking result. The key is careful placement: injections should be placed laterally enough to avoid the risk of any diffusion toward the levator palpebrae muscle (the eyelid elevator). This is standard technique knowledge for any experienced injector, but it is worth understanding as a patient so you can ask your provider about their approach.
Lower Face and Neck: Precision Is Non-Negotiable
Any neuromodulator application in the lower face, lip lines, dimpled chin (mentalis), neckbands (platysma), depressor anguli oris (the corners of the mouth), requires the highest level of injector precision. The lower face is densely populated with muscles that serve critical functions in eating, speaking, and expression, and inadvertent spread can cause meaningful functional impairment.
For all lower face applications, Botox and Xeomin are generally preferred over Dysport because their more contained diffusion radius gives the injector better control over the treatment endpoint. Dysport is not contraindicated in the lower face, but it demands even greater technical precision to achieve the intended result without affecting adjacent muscle groups.
Jawline Slimming and Masseter Reduction
Masseter botulinum toxin injections for jaw slimming have become one of the most requested treatments we see, particularly among our NYC and Miami Beach clients who are interested in a more oval or V-shaped lower face contour. The masseter is one of the largest and strongest muscles in the face, and it responds well to neuromodulator treatment, though results in this area take longer to become visible (typically 4–6 weeks for the full slimming effect to appear as the muscle gradually reduces in bulk).
Botox is the most commonly used product for masseter treatment, partly because of provider familiarity and partly because the dosing is well-characterized in this area. Dysport can be used effectively, but the broader diffusion requires careful attention to placement to avoid inadvertent spread to the zygomaticus major (the smiling muscle), which can affect smile symmetry. This is a case where experience with the specific muscle anatomy matters more than product selection.
What Anti-Aging Injections Actually Cannot Do (And What to Pair Them With)
One of the most important conversations we have at every new patient consultation is setting accurate expectations about what neuromodulators can and cannot accomplish. Anti-aging injections are genuinely powerful tools for dynamic wrinkles, the lines that form as a direct result of muscle movement. But they have inherent limitations that no amount of product or technique can fully overcome.
Dynamic vs Static Wrinkles: The Core Distinction
Dynamic wrinkles form during facial expressions and disappear (or at least diminish) when the face is at rest. These are the primary targets for neuromodulators, and they respond very well to treatment. Static wrinkles, by contrast, are visible even when the face is completely relaxed, they are etched into the skin surface through years of repeated folding, collagen loss, and volume depletion. Neuromodulators can improve static wrinkles over time by reducing the repetitive folding motion that created them, but they cannot fully erase lines that are already deeply set into the dermis.
For static wrinkles and volume loss, dermal fillers (Juvéderm, Restylane) are the appropriate complementary treatment. For skin texture, tone, and surface quality, treatments like Morpheus8 RF microneedling, Lumecca IPL, or clinical resurfacing protocols add the layer of improvement that injectables alone cannot provide. This is why we frequently discuss combination treatment plans with clients who come in specifically looking for anti-aging injections, the most comprehensive facial rejuvenation typically involves neuromodulators working alongside other modalities rather than as a standalone solution.
The "Preventative Botox" Question
One of the most common questions we receive from clients in their late 20s and early 30s is whether starting neuromodulator treatment earlier can prevent the formation of deeper lines later in life. The clinical reasoning is sound: by reducing the frequency and intensity of repetitive muscle contractions before the skin begins showing the cumulative effects of those contractions, you theoretically reduce the rate at which dynamic lines deepen into static ones.
The evidence supporting this approach is growing, and many dermatologists and aesthetic providers endorse it for appropriate candidates. However, "appropriate" is the operative word. Not everyone in their 20s has expressive enough lines or muscle activity to justify regular neuromodulator treatment, and the decision should always be made in the context of a thorough in-person assessment rather than purely as a prophylactic measure. We recommend scheduling a consultation to evaluate your specific muscle activity patterns and skin quality before committing to a preventative treatment plan.
Pricing: What to Realistically Expect for Botox, Dysport, and Xeomin in NYC, Boston, and Miami
Pricing for neuromodulators varies considerably by geography, provider type, and the specific areas being treated. Understanding the pricing structure helps you evaluate quotes accurately and avoid the trap of chasing the lowest unit price without accounting for the total units needed.
| Treatment Area | Typical Units (Botox/Xeomin) | Typical Units (Dysport) | NYC/Boston/Miami Market Range (Estimate) |
|---|---|---|---|
| Forehead only | 10–20 units | 30–60 units | $200–$500 |
| Glabellar (11s) | 20–25 units | 50–70 units | $250–$550 |
| Crow's feet (both sides) | 12–24 units | 30–60 units | $200–$500 |
| Upper face (all three zones) | 40–64 units | 100–160 units | $550–$1,400 |
| Masseter (jaw slimming) | 40–60 units/side | 100–150 units/side | $700–$1,500 |
| Hyperhidrosis (underarms) | 50–100 units/underarm | Variable | $900–$1,800 total |
| Neck bands (platysma) | 25–50 units | Variable | $400–$900 |
Note: These are estimated market ranges for major metropolitan areas. Actual pricing at Skin Spa New York is determined at consultation based on the specific units required for your anatomy and treatment goals. We strongly recommend evaluating total treatment cost rather than per-unit price alone, a lower unit cost from a less experienced provider often means more units used less efficiently.
One pricing consideration that frequently comes up in consultations is the Botox Boston market versus Manhattan pricing. Our clients at our Back Bay and North Station locations often find that pricing in Boston is modestly lower than comparable Manhattan rates, which reflects real estate and overhead differences rather than any difference in product quality or provider credentials. The same FDA-approved products, the same treatment protocols, and the same clinical oversight apply across all of our locations.
The Provider Experience Question: Why It Matters More Than the Product
We want to be direct about something that gets underemphasized in most consumer guides: the single most important variable in the outcome of any neuromodulator treatment is the skill and experience of the provider administering it. The difference between a beautiful, natural-looking result and a frozen, uneven, or functionally compromised one is almost never about which product was used, it is about who used it and how.
What to Look for in an Injection Provider
When evaluating any practice where you are considering anti-aging injections, the questions that matter most are:
- What are the provider's credentials? In the US, neuromodulator injections should be administered by or under the direct supervision of a licensed medical professional, a physician, nurse practitioner, physician assistant, or registered nurse working under physician oversight. The specific scope-of-practice rules vary by state, but the principle is consistent: aesthetic injections are a medical procedure and should be treated as such.
- How many neuromodulator treatments has this provider personally administered? Experience in this field is genuinely cumulative. An injector who has treated hundreds of faces has developed the pattern recognition to identify anatomical variation, anticipate how a particular patient's muscles will respond, and adjust technique accordingly. This is not something that can be learned from a weekend training course.
- Does the practice have medical oversight? At Skin Spa New York, every injectable treatment is performed within a medically supervised environment, with our Medical Director available for clinical guidance and our protocols reviewed regularly for safety and efficacy standards.
- Is the product being used genuinely FDA-approved, properly stored, and administered from an unopened vial? The rise of "Botox parties" and deeply discounted injection events has unfortunately created a market for improperly stored, diluted, or outright counterfeit product. The FDA has issued warnings about counterfeit botulinum toxin products, a very real safety concern that patients should be aware of when evaluating unusually low-priced providers.
The Consultation Process: What Should Happen Before Any Injection
A properly conducted injectable consultation includes a review of your medical history (including any neuromuscular conditions, pregnancy status, and current medications), an assessment of your facial anatomy at rest and in motion, a discussion of your aesthetic goals and realistic expectations, and a clear explanation of the treatment plan including product selection, dosing rationale, and what to expect in terms of onset, duration, and downtime.
If a provider wants to skip straight to injection without a thorough assessment, especially on a first visit, that is a meaningful red flag. The time spent in consultation directly informs the quality of the treatment plan.
Decision Framework: Choosing the Right Neuromodulator for Your Goals
Based on our clinical experience across thousands of neuromodulator treatments, here is the decision framework we use internally when helping patients choose between Botox, Dysport, and Xeomin. This is not a replacement for an in-person consultation, but it gives you a starting point for that conversation.
| Your Situation | Recommended Starting Point | Reasoning |
|---|---|---|
| First-time injectable patient | Botox | Longest track record, most provider experience, easiest to titrate for first-time results |
| Event in 5–7 days, need faster onset | Dysport | 24–48 hour initial onset gives better timing predictability for short windows |
| Strong forehead with horizontal banding after Botox | Dysport | Broader diffusion produces more even coverage across large frontalis muscle |
| Lower face treatment (lips, chin, corners of mouth) | Botox or Xeomin | Controlled diffusion radius essential for lower face precision |
| Long-term patient (5+ years) with diminishing results | Xeomin | Zero accessory proteins may restore responsiveness in patients with possible antibody development |
| Sensitive patient wanting minimal protein exposure | Xeomin | Pure toxin formulation, no accessory proteins |
| Masseter reduction / jaw slimming | Botox (primary) or Dysport (with experienced provider) | Well-characterized dosing in this area; Dysport requires extra precision near zygomaticus |
| Preventative treatment in late 20s/early 30s | Botox or Xeomin | Conservative dosing for subtle results; provider familiarity and precision matter most at lower doses |
| Crow's feet, broad lateral orbital softening | Dysport | Broader diffusion creates even softening of entire lateral orbital zone |
What to Expect: Before, During, and After Your Treatment
Understanding the full treatment experience helps reduce anxiety for first-time patients and helps experienced patients get more out of each visit. Here is what the process looks like at our locations across Manhattan, Boston, and Miami.
Before Your Appointment
In the week before your neuromodulator treatment, avoid blood-thinning supplements and medications (including fish oil, vitamin E, aspirin, and NSAIDs like ibuprofen) unless prescribed for a medical condition, these increase bruising risk. Alcohol should be avoided in the 24–48 hours before treatment for the same reason. Arrive to your appointment with a clean face, and if you have any active skin infections, cold sores, or rashes in the treatment area, let your provider know so the appointment can be rescheduled if appropriate.
During the Treatment
The injections themselves are brief, typically 10–20 minutes for a standard upper face treatment. A very fine needle is used, and most patients describe the sensation as a quick pinch. Topical numbing cream is available at our locations for patients who are particularly sensitive, though many clients find they do not need it. You may notice small bumps at each injection site immediately after treatment, these resolve within 20–30 minutes.
After Your Treatment: What Not to Do
For the first four hours after treatment, avoid lying flat, bending over significantly, or engaging in vigorous exercise. These activities can theoretically cause the product to migrate before it has fully bound at the neuromuscular junction. Avoid rubbing or massaging the treated areas. You can resume normal activities the same day, including light makeup application, but save intense workouts for the next day.
Most patients experience no meaningful downtime. Minor bruising (most common in the crow's feet area) can occur and typically resolves within 3–7 days. Headache is occasionally reported on the day of treatment and usually resolves with over-the-counter pain relief. Any concerns about asymmetry or unexpected effects should be communicated to your provider within the first two weeks, as this is within the window where a touch-up can refine the result.
The Touch-Up Appointment
Many providers, including our team, recommend scheduling a two-week follow-up for new patients. This allows the provider to assess the full result and make any minor adjustments before the treatment window closes. Over time, as your provider develops a detailed picture of how your muscles respond to specific products and doses, results typically become more consistent and touch-ups less frequently needed.
Frequently Asked Questions About Botox, Dysport, and Xeomin
Is Dysport cheaper than Botox?
Not necessarily on a per-treatment basis. Dysport is priced per unit, but because Dysport units are dosed at roughly 2–3 times the number of Botox units to achieve equivalent clinical effect, the total cost of a Dysport treatment is often comparable to Botox. The per-unit price is not a reliable comparison point across products, compare total treatment cost for the same area instead.
How long does Botox last in the forehead?
For most patients, Botox for forehead treatment lasts approximately 3–4 months. Patients who maintain a consistent treatment schedule over several years often find duration extends toward 4–6 months as the underlying muscle activity gradually reduces. Factors like metabolism, exercise habits, and muscle mass all influence individual duration.
Can I switch between Botox, Dysport, and Xeomin?
Yes, and switching is sometimes clinically beneficial. If you have been using one product for years and feel your results are diminishing or inconsistent, trying a different formulation can refresh the response. Always inform your provider of your full treatment history, including which products you have received, the approximate doses, and how long you have been receiving treatments.
What is the best neuromodulator for crow's feet?
All three products are effective for crow's feet, but many providers find Dysport particularly well-suited to this area because its broader diffusion radius can cover the full extent of the lateral orbicularis oculi with fewer injection points. The most important factor is provider technique and experience in the periorbital area, regardless of product.
Is Xeomin weaker than Botox?
No. Xeomin is not weaker, it contains only the pure botulinum toxin type A without the accessory proteins found in Botox and Dysport. At appropriately calibrated doses (roughly one-to-one with Botox units in most areas), Xeomin produces comparable results. The absence of accessory proteins is a formulation difference, not a potency disadvantage.
Can Botox or Dysport be used for hyperhidrosis (excessive sweating)?
Yes. Botox has FDA approval specifically for primary axillary hyperhidrosis (excessive underarm sweating), and it is also used off-label for palmar and plantar hyperhidrosis. Dysport and Xeomin are used in similar applications. The mechanism is the same, blocking the acetylcholine signals that stimulate sweat glands, and results typically last 6–12 months in this application, longer than facial treatment duration.
How soon before an event should I get neuromodulator treatment?
For Botox or Xeomin, schedule at least 14 days before the event to allow for full result development and any needed touch-up. For Dysport, 10–12 days is typically sufficient given its faster onset. Never get your first-ever neuromodulator treatment immediately before an important event, allow yourself a treatment cycle to understand how your face responds before timing a session to an occasion.
Does it hurt?
Most patients describe the sensation as a brief, mild pinch. The needles used for neuromodulator injections are very fine gauge, and the volume of product per injection site is tiny. The glabellar area can be slightly more sensitive for some patients. Topical numbing cream is available at our locations if you prefer additional comfort.
What happens if I stop getting treatments?
Your muscles simply return to their normal activity level, and the lines that were softened will gradually return. There is no rebound effect, your face does not wrinkle faster or more severely after stopping treatment. If you have been receiving treatments for many years, the underlying muscle may have partially atrophied (reduced in bulk), which means lines may return more slowly than before you started.
Is Botox safe for long-term use?
The safety profile of botulinum toxin type A for cosmetic use has been studied for decades. For patients receiving treatments at appropriate intervals and doses, long-term cosmetic use is considered safe by the dermatology and plastic surgery communities. As with any medical treatment, it should be administered by qualified providers using properly stored, FDA-approved product, and your full health history should be disclosed to your provider before each treatment series.
Can Botox be combined with fillers or other treatments?
Yes, and combination treatment plans are very common. Neuromodulators address dynamic wrinkles and muscle activity; dermal fillers (Juvéderm, Restylane) address volume loss and static lines; and skin resurfacing treatments like Morpheus8 or Lumecca IPL address texture, tone, and surface quality. Many of our clients receive neuromodulators and fillers in the same appointment, and we often recommend pairing injectable treatment with a HydraFacial or medical-grade peel for comprehensive skin health maintenance.
What makes Botox Boston pricing different from Manhattan?
Geographic differences in overhead costs (rent, staffing, operating expenses) are the primary driver of pricing variation between markets. Our Boston locations at Back Bay and North Station use identical products, protocols, and clinical standards as our Manhattan practices. Pricing differences reflect market economics rather than any difference in quality or provider credentials.
Key Takeaways
- All three neuromodulators (Botox, Dysport, Xeomin) are FDA-approved and effective, the "best" one depends on your face, your treatment goals, and your provider's experience with each product.
- Dysport has the fastest onset (24–48 hours) and the broadest diffusion, making it particularly well-suited for large treatment areas like the forehead and crow's feet.
- Botox remains the benchmark, the most extensively studied, most widely administered, and the product most providers have the deepest experience with. It is an excellent starting point for most patients.
- Xeomin is the best choice for long-term injectable patients who may be developing antibody resistance, or for anyone who wants the lowest possible protein load in their treatment.
- Dosing units are not interchangeable across products, always compare total treatment cost, not per-unit price, when evaluating quotes from different providers or products.
- Provider skill is the most important variable in your outcome, more important than which product is selected. Seek out medically supervised practices with experienced, credentialed injectors.
- Botox for forehead treatment is one of the most commonly performed and most studied applications, all three products work here, with Dysport offering broader coverage for strong frontalis muscles.
- Neuromodulators work best as part of a broader skin health strategy, pairing them with appropriate skincare, dermal fillers where indicated, and skin resurfacing treatments produces the most comprehensive anti-aging results.
- Schedule a consultation before